These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 2319808)
1. Proliferation and differentiation of erythroleukemia cell line (ELM-I-1) in response to erythropoietin and interleukin 3. Shiozaki M; Itoh K; Mori KJ Leuk Res; 1990; 14(3):287-91. PubMed ID: 2319808 [TBL] [Abstract][Full Text] [Related]
2. Both stroma and stem cell factor maintain long-term growth of ELM erythroleukemia cells, but only stroma prevents erythroid differentiation in response to erythropoietin and interleukin-3. O'Prey J; Leslie N; Itoh K; Ostertag W; Bartholomew C; Harrison PR Blood; 1998 Mar; 91(5):1548-55. PubMed ID: 9473219 [TBL] [Abstract][Full Text] [Related]
3. Alteration of nuclear proto-oncogene expression by erythropoietin (Epo) in Epo-responsive murine cell lines. Tsuda H; Aso N; Sawada T; Hata H; Kawakita M; Mori KJ; Takatsuki K Int J Cell Cloning; 1991 Mar; 9(2):123-33. PubMed ID: 2037810 [TBL] [Abstract][Full Text] [Related]
4. Erythropoietin rapidly reduces phosphorylation of a membrane protein in a murine erythroleukemia cell line. Sawada T; Tsuda H; Mori KJ; Kawakita M; Takatsuki K Int J Hematol; 1991 Apr; 54(2):109-15. PubMed ID: 1836139 [TBL] [Abstract][Full Text] [Related]
5. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity. Murate T; Yamashita K; Ohashi H; Kagami Y; Tsushita K; Kinoshita T; Hotta T; Saito H; Yoshida S; Mori KJ Exp Hematol; 1993 Jan; 21(1):169-76. PubMed ID: 8417953 [TBL] [Abstract][Full Text] [Related]
6. An activating mutation in the kit receptor abolishes the stroma requirement for growth of ELM erythroleukemia cells, but does not prevent their differentiation in response to erythropoietin. Leslie NR; O'Prey J; Bartholomew C; Harrison PR Blood; 1998 Dec; 92(12):4798-807. PubMed ID: 9845547 [TBL] [Abstract][Full Text] [Related]
7. Interleukin-2 (IL-2) induces erythroid differentiation and tyrosine phosphorylation in ELM-I-1 cells transfected with a human IL-2 receptor beta chain cDNA. Imada K; Tsudo M; Kodaka T; Itoh K; Arima N; Hattori T; Okuma M; Uchiyama T Biochem Biophys Res Commun; 1992 Oct; 188(1):352-7. PubMed ID: 1384486 [TBL] [Abstract][Full Text] [Related]
8. Wortmannin, a specific inhibitor of phosphatidylinositol-3-kinase, inhibits erythropoietin-induced erythroid differentiation of K562 cells. Kubota Y; Tanaka T; Yamaoka G; Yamaguchi M; Ohnishi H; Kawanishi K; Takahara J; Irino S Leukemia; 1996 Apr; 10(4):720-6. PubMed ID: 8618453 [TBL] [Abstract][Full Text] [Related]
9. Erythropoietin-induced cellular differentiation requires prolongation of the G1 phase of the cell cycle. Carroll M; Zhu Y; D'Andrea AD Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2869-73. PubMed ID: 7708739 [TBL] [Abstract][Full Text] [Related]
10. Epo regulates erythroid proliferation and differentiation through distinct signaling pathways: implication for erythropoiesis and Friend virus-induced erythroleukemia. Zochodne B; Truong AH; Stetler K; Higgins RR; Howard J; Dumont D; Berger SA; Ben-David Y Oncogene; 2000 May; 19(19):2296-304. PubMed ID: 10822380 [TBL] [Abstract][Full Text] [Related]
11. Establishment and characterization of an erythropoietin-dependent subline, UT-7/Epo, derived from human leukemia cell line, UT-7. Komatsu N; Yamamoto M; Fujita H; Miwa A; Hatake K; Endo T; Okano H; Katsube T; Fukumaki Y; Sassa S Blood; 1993 Jul; 82(2):456-64. PubMed ID: 8329702 [TBL] [Abstract][Full Text] [Related]
13. Rapid protein tyrosine phosphorylation selectively induced in murine responsive ELM-I-1 cells by erythropoietin. Sawada T; Tsuda H; Kawakita M; Takatsuki K Exp Hematol; 1992 Jun; 20(5):629-32. PubMed ID: 1587309 [TBL] [Abstract][Full Text] [Related]
14. Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation. Chrétien S; Varlet P; Verdier F; Gobert S; Cartron JP; Gisselbrecht S; Mayeux P; Lacombe C EMBO J; 1996 Aug; 15(16):4174-81. PubMed ID: 8861946 [TBL] [Abstract][Full Text] [Related]
15. Specific binding of erythropoietin to its receptor on responsive mouse erythroleukemia cells. Todokoro K; Kanazawa S; Amanuma H; Ikawa Y Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4126-30. PubMed ID: 3035570 [TBL] [Abstract][Full Text] [Related]
17. Growth signal erythropoietin activates the same tyrosine kinases as interleukin 3, but activates only one tyrosine kinase as differentiation signal. Kuramochi S; Chiba T; Amanuma H; Tojo A; Todokoro K Biochem Biophys Res Commun; 1991 Dec; 181(3):1103-9. PubMed ID: 1722396 [TBL] [Abstract][Full Text] [Related]
18. Identification and analysis of human erythropoietin receptors on a factor-dependent cell line, TF-1. Kitamura T; Tojo A; Kuwaki T; Chiba S; Miyazono K; Urabe A; Takaku F Blood; 1989 Feb; 73(2):375-80. PubMed ID: 2537111 [TBL] [Abstract][Full Text] [Related]
19. Erythropoietin-dependent suppression of the expression of the beta subunits of the interleukin-3 receptor during erythroid differentiation. Carta C; Campisi S; Migliaccio G; Migliaccio AR Blood Cells Mol Dis; 2000 Oct; 26(5):467-78. PubMed ID: 11112384 [TBL] [Abstract][Full Text] [Related]
20. Dependence for the proliferative response to erythropoietin on an established erythroid differentiation program in a human hematopoietic cell line, UT-7. Nicolis S; Ottolenghi S; Papayannopoulou T; Baiocchi M; Migliaccio G; Adamson J; Migliaccio AR Exp Hematol; 1993 May; 21(5):665-70. PubMed ID: 8513868 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]